IQVIA Holdings Inc (IQV)
IQVIA Holdings Inc (IQV) carries a ŷRobot AI score of 59 out of 100. The model's fair value estimate is $261.57, 0.2% below the last close of $262.12. The chart signal reads Bearish.
| Metric | IQV |
|---|---|
| AI score | 59 / 100 |
| Chart signal | Bearish |
| Fair value estimate | $261.57 |
| Upside to fair value | -0.2% |
| Previous close | $262.12 |
| P/E | 33.16 |
| Price / sales | 2.53 |
| Market cap | $43.04B |
| EPS | 8.04 |
| Revenue growth | 4.0% |
| 1-year price change | 4.1% |
How these numbers are built: the AI score, the fair value model, and the chart signal.
Other Healthcare stocks: Eli Lilly and Company, Johnson & Johnson, AbbVie Inc, Merck & Company Inc, UnitedHealth Group Incorporated, Novartis AG ADR.
Questions about IQV
Is IQV overvalued or undervalued right now?
As of Oct 14, 2026, ŷRobot's fair-value model estimates IQVIA Holdings Inc (IQV) at $261.57 against a last close of $262.12, implying 0.2% downside to the model's estimate.
Is IQV's chart signal bullish or bearish?
The chart-signal model classifies IQV as Neutral as of Oct 14, 2026, with a signal score of -0.10 on a -1 to 1 scale.
What is IQV's ŷRobot AI score?
IQV scores 59 out of 100 on ŷRobot's AI composite, which measures how strongly the fair-value and chart models agree, as of Oct 14, 2026.
Is IQV stock expensive on P/E and P/S?
IQV trades at 33.2 times earnings and 2.5 times sales as of Oct 14, 2026.
What does IQV's seasonal forecast show?
ŷRobot's seasonal forecast curve for IQV reads +1.2% at 30 days, +4.4% at 90 days, and +4.1% at one year as of Oct 14, 2026. Seasonal tendencies are historical patterns, not predictions.
How fast is IQV growing?
IQVIA Holdings Inc's revenue growth is +4.0% and free-cash-flow growth is -0.2% on the latest reported figures.
IQV chart and technical read · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.